DEVELOPMENT OF CD46 TARGETED ANTIBODY FRAGMENT RADIOPHARMACEUTICAL THERAPY FOR TREATMENT OF PROSTATE CANCER
$1,967,999FY2025Defense Health AgencyDOD
Regents Of The University Of California, San Francisco, The
Regents Of The University Of California, San Francisco, The